Antibodies Blocking IL-10 Found in About 3.5% of IBD Patients, Study Reports
A New England Journal of Medicine study of more than 4,900 people with inflammatory bowel disease links autoantibodies against interleukin-10 to a long-known genetic risk variant, pointing toward a possible blood test and targeted treatment.
Read MoreViews: (15)